0001209191-15-056416.txt : 20150625 0001209191-15-056416.hdr.sgml : 20150625 20150625174204 ACCESSION NUMBER: 0001209191-15-056416 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20150625 FILED AS OF DATE: 20150625 DATE AS OF CHANGE: 20150625 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Seres Therapeutics, Inc. CENTRAL INDEX KEY: 0001609809 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 274326290 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 440 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617 945 9626 MAIL ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 440 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Seres Health, Inc. DATE OF NAME CHANGE: 20140603 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pomerantz Roger CENTRAL INDEX KEY: 0001614936 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37465 FILM NUMBER: 15952616 MAIL ADDRESS: STREET 1: 711 HARVEST HILL ROAD CITY: CHALFONT STATE: PA ZIP: 18914 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2015-06-25 0 0001609809 Seres Therapeutics, Inc. MCRB 0001614936 Pomerantz Roger C/O SERES THERAPEUTICS, INC. 215 FIRST STREET CAMBRIDGE MA 02142 1 1 0 0 President and CEO Stock Option (right to buy) 0.48 2023-11-06 Common Stock 220000 D Stock Option (right to buy) 0.71 2024-08-07 Common Stock 1675751 D Series B Convertible Preferred Stock Common Stock 22727 D The option vested as to 25% of the shares on September 9, 2014. The remainder of the shares vested or will vest in 12 equal quarterly installments thereafter. The option vested as to 25% of the shares on June 1, 2015. The remainder of the shares vested or will vest in 12 equal quarterly installments thereafter. The Series B Convertible Preferred Stock is convertible into Common Stock on a one-for-one basis and has no expiration date. Each share of Series B Convertible Preferred Stock will convert to Common Stock upon the listing of the issuer's securities on The NASDAQ Global Select Market. Exhibit List: Exhibit 24 - Power of Attorney /s/ Eric D. Shaff, Attorney-in-Fact 2015-06-25 EX-24 2 attachment1.htm EX-24 DOCUMENT

                                                                      Exhibit 24

                                POWER OF ATTORNEY

        KNOW ALL BY THESE PRESENTS, as of this 27th day of April, 2015, that the
undersigned hereby constitutes and appoints the Chief Executive Officer of Seres
Health, Inc. (the "Company"), who is currently Roger J. Pomerantz, and the Chief
Financial Officer of the Company who is currently Eric D. Shaff, or either of
them signing singly, and with full power of substitution, the undersigned's true
and lawful attorney-in-fact to:

     (1)  prepare, execute in the undersigned's name and on the undersigned's
          behalf, and submit to the U.S. Securities and Exchange Commission (the
          "SEC") a Form ID, including amendments thereto, and any other
          documents necessary or appropriate to obtain codes and passwords
          enabling the undersigned to make electronic filings with the SEC of
          reports required by Section 16(a) of the Securities Exchange Act of
          1934 or any rule or regulation of the SEC;

     (2)  execute for and on behalf of the undersigned, in the undersigned's
          capacity as an officer and/or director of Seres Health, Inc. (the
          "Company"), Forms 3, 4, and 5 in accordance with Section 16(a) of the
          Securities Exchange Act of 1934 and the rules thereunder;

     (3)  do and perform any and all acts for and on behalf of the undersigned
          which may be necessary or desirable to complete and execute any such
          Form 3, 4, or 5, complete and execute any amendment or amendments
          thereto, and timely file such form with the SEC and any stock exchange
          or similar authority; and

     (4)  take any other action of any type whatsoever in connection with the
          foregoing which, in the opinion of such attorney-in-fact, may be of
          benefit to, in the best interest of, or legally required by, the
          undersigned, it being understood that the documents executed by such
          attorney-in-fact on behalf of the undersigned pursuant to this Power
          of Attorney shall be in such form and shall contain such terms and
          conditions as such attorney-in-fact may approve in such
          attorney-in-fact's discretion.

        The undersigned hereby grants to each such attorney-in-fact full power
and authority to do and perform any and every act and thing whatsoever
requisite, necessary, or proper to be done in the exercise of any of the rights
and powers herein granted, as fully to for me to fix your for all intents and
purposes as the undersigned might or could do if personally present, with full
power of substitution or revocation, hereby ratifying and confirming all that
such attorney-in-fact, or such attorney-in-fact's substitute or substitutes,
shall lawfully do or cause to be done by virtue of this power of attorney and
the rights and powers herein granted. The undersigned acknowledges that the
foregoing attorneys-in-fact, in serving in such capacity at the request of the
undersigned, are not assuming, nor is the Company assuming, any of the
undersigned's responsibilities to comply with Section 16 of the Securities
Exchange Act of 1934.

        This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorneys-in-fact.

        IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to
be executed as of the date first written above.

                                        /s/ Roger J. Pomerantz
                                        ---------------------------------------
                                        Signature

                                        Roger J. Pomerantz
                                        ---------------------------------------
                                        Printed Name